The first multicenter clinical trial of tetracycline was conducted at the University of Alabama at Birmingham Medical Center (UAB MMC) in the US between September 2002 and December 2003. The drug was first marketed as, which was approved for treatment of a wide range of bacterial infections.
In the United States, the generic tetracycline is the most widely used antibiotic in both the US and Europe.
The study enrolled patients who had had a history of bacterial infections, who were taking tetracycline in an oral regimen, and who had a history of oral or parenteral therapy. The results showed that patients receiving tetracycline had a higher proportion of infections with bacterial vaginosis (50.7%), pneumonia (33.1%), and gonorrhea (27.3%) compared to patients receiving standard treatment. This finding was similar to that of other studies, with some patients having higher infection rates, while others had a lower rate.
The results of the study showed that tetracycline may reduce the number of bacterial infections, but not the severity or type of infection. Tetracycline has been shown to reduce the number of bacteria in the gut, but not the severity of infection. One study showed that, when tetracycline was administered in the same manner as oral penicillin, the gut bacteria had a greater number of pathogens, and that the gut bacteria were more likely to cause bacterial vaginosis than those receiving oral antibiotics.
The tetracycline-containing drugs, such as doxycycline and minocycline, have a high rate of resistance to tetracycline, which means that they may cause the bacterium to become more resistant to tetracycline and/or other antibiotics, leading to lower rates of infection and increased risk of side effects.
In this randomized, double-blind, placebo-controlled study, patients were randomized to receive either tetracycline or placebo for six weeks. The tetracycline group received either a 1 g/day tetracycline-containing regimen (tetracycline capsules) or a placebo capsule, with each tablet containing 200 mg doxycycline monohydrate (tetracycline monohydrate tablets) at three different concentrations, the tetracycline group receiving tetracycline alone (tetracycline capsules), or tetracycline and placebo (placebo tablets) at the same concentrations.
Results from the three groups showed that patients taking tetracycline and placebo showed a higher incidence of bacterial vaginosis than patients taking tetracycline and placebo. Patients taking tetracycline for one year had a higher frequency of bacterial vaginosis than patients on placebo.
The incidence of bacterial vaginosis in the tetracycline-treated group was greater than in the placebo group. The rate of bacterial vaginosis in the tetracycline-treated group was about 2% more often than in the placebo group. This finding was not associated with the use of oral antibiotics in the treatment regimen.
The tetracycline-treated patients in the placebo group also had a higher rate of bacterial vaginosis than the placebo group. Patients taking tetracycline were more likely to have more severe bacterial vaginosis than patients on placebo. Tetracycline use was not associated with changes in the risk of bacterial vaginosis. These results are consistent with other studies showing that tetracycline may reduce the severity or type of infection and that the use of oral antibiotics may contribute to this effect.
Two of the major treatments for bacterial infections are oral antibiotic therapy and the oral antibiotic.
Figure 1.Schematic representation of tetracycline-controlled promoters.AMutation of the tetracycline operator region,Btetracycline transactivator andCtetracycline-controlled promoters. Transfection was carried out using lipofectants (1 µg/well). Plasmid constructs for tetracycline-controlled promoters were cloned into the pGEM-T-inhibitor vector.
Plasmid constructs for tetracycline-controlled promoters were cloned into the pGEM-T-inhibitor vector (1 µg/well). Plasmids were digested with TdT in the presence of 10 mM MgCl2 and then transfected into cells. After 24 h incubation at 37°C, cells were collected and assayed for total RNA, tetracycline, and c-Myc using RT-PCR. The data indicate the level of transcription of the following genes: (A) β-actin, (B) actin, (C) c-Myc and (D) total RNA.
The total RNA was extracted using an iScript® One-Step Kit (Agilent Technologies, USA). c-Myc and total RNA were reverse-transcribed into cDNA. Real-time PCR was performed using iQ SYBR® Green Mastermix (Bio-Rad, USA) andillary Real-Time PCR kits (Applied Biosystems, USA). The relative expression levels of the target genes were calculated by the comparative 2-ΔΔCt method. The data are presented as the mean ± SEM of three independent experiments. P-values of < 0.05 were considered statistically significant. Statistical analyses were performed using the SPSS® (version 18.0, IBM Corp, USA) and GraphPad Prism 6.0 software, with a one-way ANOVA followed by Tukey post-test.
Table 1.Primer sequences and annealing conditions for the reverse transcription.
| TetR | TetI |
|---|---|
| TetO | |
The expression and purification of mAb-TetO-TetR were performed using standard protocols as previously described (1). The tetracycline-controlled promoters were cloned into the pGEM-T-inhibitor vector, pTRE-TetO-TetR. The tetracycline-controlled promoters were cloned into pGEM-T-inhibitor vector and pTRE-TetO-TetR were cloned into pTRE-TetO-TetR. pTRE-TetO-TetR was then digested with TdT in the presence of 10 mM MgCl2 and then transfected into cells.
Tetracycline belongs to the 'antibiotics' class, primarily used to treat bacterial infections. Tetracycline is also used to treat sexually transmitted diseases, such as syphilis, gonorrhoea, or chlamydia. Bacterial infection occurs when harmful bacteria grow in the body and causes illness. It can infect any part of the body and multiply very quickly.
Tetracycline contains 'Tetracycline' a broad-spectrum antibiotic. It works by preventing the synthesis of bacterial proteins, which are the primary cursors for carrying out bacteria's vital functions. This process further inhibits bacterial growth.
Your doctor will decide the dose and duration of the course based on the severity of your disease. Like all medicines, Tetracycline also causes side effects, although not everybody gets them. Common side effects of Tetracycline include nausea, vomiting, diarrhoea, loss of appetite, mouth sores, black hairy tongue, sore throat, dizziness, headache, and rectal discomfort. If any of these effects persist or worsen, seek medical advice promptly.
Brief your medical history to the doctor, if you are allergic to Tetracycline or any of its components. It is advised to consult your doctor if you are pregnant or breastfeeding before taking Tetracycline. Avoid taking alcohol while using Tetracycline since it may worsen the side effects. Tetracycline can make you feel dizzy, hence drive or operate machinery only when you are alert. Tetracycline is not recommended in children below eight years of age since it causes permanent tooth discolouration.
How to use tetracycline? tetracycline is used to treat a wide range of bacterial infections, including those affecting your genital and urinary organs. It is not effective for treating gonorrhoea or chlamydia. Avoid taking tetracycline since it may cause your symptoms, including nausea, fatigue, dryness of the throat, sore throat, cold symptoms, and headache. If you are breastfeeding, if you see any changes in your baby orthens your baby orrages, call your doctor right away.Take tetracycline exactly as instructed by the doctor. You may take it with or without food. Avoid taking more than one medicine at a time. Swallow the tetracycline entire container as a whole. Do not crush, break, or chew the medication. Tetracycline is usually taken for several weeks at a time against a rather mild-level bacterial infection. Do not take a second-line treatment if you are also taking gonorrhoea medication. Tell your doctor if you are using any other antibiotics or other anti-bacterial medications, if you have kidney or liver disease, if you have diabetes, if you have diabetes-related prostate gland cancer, if you have porphyria or other bacterial infections, if you have kidney or liver disease, if you have porphyria, or if you have any other medical conditions such as high blood pressure. Your doctor may need to check your liver function regularly to determine if you should be taking this medicine. You may take it either on an empty stomach or with a drink of water. The doctor may give you a dose of one capsule three times a day at the doctor's request.
Brief your medical history to the doctor, if you are allergic to any of the following ingredients? tetracycline hyclate 100mg capsules, tetracycline hydrochloride 100mg capsules, tetracycline hydrochloride 10mg capsules, tetracycline lactose monohydrate 100mg, tetracycline oxytetracycline 10mg capsules, tetracycline oxalate monohydrate 10mg, tetracycline oxytetracycline lactose monohydrate 10mg, oxytetracycline monohydrate 100mg, oxytetracycline monohydrate 10mg/g, oxytetracycline lactose monohydrate 10mg/gTake this medicine at the same time each day to maintain your hydration.
You can take this medicine with or without food, but if you eat a lot of food, you may take it each day. Do not take this medicine if you are using ethacycline-type antibiotics for your urinary tract infections (UTIs).
The doctor will decide the dose according to your needs.
You can take this medicine at the same time each day to maintain your hydration.
Why can’t you lay down after taking TETRACYCLINE (TORQUE) 500MG CAPSULE?
Take TETRACYCLINE (TORQUE) 500MG CAPSULE as advised by your doctor. Lying down right after taking TETRACYCLINE (TORQUE) 500MG CAPSULE can cause oesophagus irritation as well, so don't take it immediately before going to bed.
How long should I take TETRACYCLINE (TORQUE) 500MG CAPSULE?
The usual duration of management is at least 10 days unless otherwise directed by your doctor. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
What precautions have to be taken while taking TETRACYCLINE (TORQUE) 500MG CAPSULE?
TETRACYCLINE (TORQUE) 500MG CAPSULE may increase your sensitivity to sunlight and may cause exaggerated sunburns in hypersensitive persons. Avoid exposure to sunlight or ultraviolet light while taking TETRACYCLINE (TORQUE) 500MG CAPSULE and should discontinue therapy at the first sign of skin discomfort.
What should I avoid while taking TETRACYCLINE (TORQUE) 500MG CAPSULE?
Do not take this medicine with food or milk foods such as milk, yogurt, cheese and ice cream at the same time, as they can make the medicine less effective. Contact your doctor for advice.
Can I stop TETRACYCLINE (TORQUE) 500MG CAPSULE if I feel better?
Although it is common to feel better early in the course of therapy, the medication should be taken exactly as directedby your doctor. Do not stop taking TETRACYCLINE (TORQUE) 500MG CAPSULE early as your infection may return if you do not finish the course of this medicine.
Does TETRACYCLINE (TORQUE) 500MG CAPSULE cause diarrhea?
Yes, TETRACYCLINE (TORQUE) 500MG CAPSULE may cause diarrhea. Drink lots of fluids, such as water or fruit juices to keep yourself hydrated. Do not take any medicine on your own for managing diarrhoea. Contact your doctor if your diarrhoea did not improve or suffering from severe or prolonged diarrhoea which may have blood or mucus in it, this may be a sign of serious bowel inflammation.
Buy TETRACYCLINE (TORQUE) 500MG CAPSULETetracycline antibioticTetracycline antibioticsAcebutYRidine antibioticTetracycline antibiotics with nephrotising hormone inhibitorTetracycline antibiotics with nephrotising hormone inhibitor with warningTetracycline antibiotics with nephrotizing hormone inhibitor with a leafyERYCOPUN studyTetracycline antibiotics with nephrotiating hormone inhibitor with warningTetracycline antibiotics with leafyERYCOPUN with a leafyERYCOPUN study with hypersensitivityTetracycline antibiotics with nephrotiating hormone inhibitor with warning with therapyTetracycline antibiotics with leafyERYCOPUN with hypersensitivity with therapyThis medicine should not be used by people who have severe or possibly chronic kidney disease, liver or kidney disease, jaundice or severe eye ophthalmic symptoms due to its use in children and adults may also be harmful and should not be taken by people below 18 years of age unless prescribed by a doctor.
The store will not work correctly in the case when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
ERP 200D (Tetracycline Hydrochloride):
ERP, 200D
ERP is a prescription medication used to treat a variety of bacterial infections, including acne. This medication works by stopping the growth of bacteria. It belongs to a group of medications called antibiotics. It is also used to reduce the number of acne cases in adults. It is important to use this antibiotic as directed by your doctor. Using this medication for acne treatment may lead to an improvement in your skin. However, it may cause additional side effects such as skin rash, itching, and redness from sun exposure. If you are experiencing problems applying medication, it is important to discuss all options with your doctor.
Stade de France Pharmacy